Latest Manufacturing News

Cambium Bio has cleared key regulatory hurdles for its lead dry eye disease treatment, Elate Ocular, and strengthened its balance sheet with a $2.12 million placement to support upcoming Phase 3 trials.

Fintech Chain Limited reported a mixed quarter with strong customer receipts and new IoT SaaS product launch, while finalising its ASX delisting. The company’s cash position tightened amid loan repayments and rising operating costs.

ABx Group Limited reports promising rare earth exploration results in Tasmania, steady progress on its ALCORE fluorine recycling pilot plant, and advancing bauxite mining projects in Queensland and Tasmania, while managing funding challenges.

Energy Technologies Limited reported a modest revenue increase and significant cash outflow improvement in its latest quarterly update, while preparing strategic moves to manage liquidity.

Hydralyte USA reported an 8.5% rise in Q2 FY25 net sales, driven by strong May performance and improved margins, while preparing to launch new brain and gut health products.

Meteoric Resources has announced a maiden Ore Reserve at its Caldeira Project alongside a breakthrough processing partnership and a heavily oversubscribed $42.5 million equity raise, positioning it as a key player in the evolving rare earths market.

Cettire warns that recent US tariff changes removing duty-free exemptions on shipments under $800 could impact nearly half its revenue. The luxury e-commerce platform is evaluating the consequences and adjusting its global strategy.

ClearVue Technologies has announced a major leadership overhaul alongside strategic partnerships and market expansion, highlighted by a solar façade trial in Hong Kong demonstrating a payback period as low as 2.6 years.

Pro-Pac Packaging reported a modest revenue increase to $62.8 million in Q4 FY25, secured a new $3 million loan facility from major shareholder Bennamon Ltd, and received a $3.5 million government grant for a recycling project facing delays.

Imugene Limited reports strong clinical progress with its off-the-shelf CAR T therapy azer-cel achieving a 75% overall response rate in Phase 1b trials, alongside new patents and leadership appointments. The company also secured $22.5 million in fresh funding to advance pivotal trials.

Perpetual Resources is advancing plans for deeper drilling at its Raptor Rare Earth Project in Brazil, aiming to unlock significant resource potential and support a maiden JORC estimate.

Burgundy Diamond Mines reported a solid Q2 2025 with increased ore production, $52 million in diamond sales, and a significant extension of the Ekati mine life. Strategic shifts and promising project updates set the stage for future growth.